Ingrid Holm, MD, MPH is currently the director of the Phenotyping Core of the Program in Genomics at Boston Children’s Hospital where she supervises the interactions between patients in the Gene Discover Core (GDC), a database and repository established for studying and storing samples and medical or family histories for individuals with rare disorders. As the director of the Phenotyping Core of the Program in Genomics, she and her colleagues have developed clinical genetic research projects in diabetes, autism, congenital heart disease and atopic dermatitis. She practices in a wide range of specialties including growth disorders, metabolic bones diseases, and sex differentiation disorders. Dr. Holm also has her own project in the genetic contributions to congenital hip dysplasia.
Dr. Holm received her medical degree from the University of California, Los Angeles and has since completed an internship, residency and post-graduate fellowship in genetics and pediatric endocrinology at Boston Children’s Hospital. Dr. Holm received a Masters in Public Health from Harvard School of Public Health. She has had an appointment at Harvard Medical School since 1992, serving as an assistant professor of pediatrics. Dr. Holm has contributed to over 22 publications in genetics related fields including research in clinical genetic testing for patients with autism spectrum disorders.
Currently, Dr. Holm works on the Genome Sequencing-Based Screening for Childhood Risk and Newborn Illness, also known as the BabySeq project, which will study the impact of genomic screening in a safe and controlled manor. She and her team plan to examine the clinical outcomes, benefits, and harms of providing genome newborn screening and having full genomic sequencing available as a resource for newborns.
The NBSTRN is excited to see the future contributions that Dr. Holm’s research will make to the newborn screening research community and we congratulate her as the researcher of the month!